Varenicline for vaping cessation has emerged as a groundbreaking solution for teens and young adults struggling to break free from nicotine addiction.Recently highlighted in a study by Harvard-affiliated Mass General Brigham, this FDA-approved medication offers hope to a demographic where vaping is alarmingly prevalent.